ClinicalTrials.gov record
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)
ClinicalTrials.gov ID: NCT00918983
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00918983. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0017
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will evaluate the safety and efficacy of a 2.5 mg dose of NX-1207 for the treatment of BPH (benign prostatic hyperplasia) as compared to placebo.
Study identification
- NCT ID
- NCT00918983
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 500 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 45 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2009 (Type not available)
- Primary completion
- Nov 2013 (Actual)
- Completion
- Nov 2013 (Actual)
- Last update posted
- Apr 30, 2014
2009 – 2013
United States locations
- U.S. sites
- 41
- U.S. states
- 22
- U.S. cities
- 41
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| For information concerning this clinical site, please contact Nymox at 800-936-9669 | Birmingham | Alabama | 35209 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Huntsville | Alabama | 35801 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Tucson | Arizona | 85712 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Little Rock | Arkansas | 72211 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Anaheim | California | 92801 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Atherton | California | 94027 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | La Mesa | California | 91942 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Long Beach | California | 90806 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Los Alamitos | California | 90720 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Denver | Colorado | 80211 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | New Britain | Connecticut | 06052 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Naples | Florida | 34102 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Ocala | Florida | 34474 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Orlando | Florida | 32806 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Tallahassee | Florida | 32308 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669 | Atlanta | Georgia | 30308 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Roswell | Georgia | 30076 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Forest Hill | Indiana | 47630 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Jeffersonville | Indiana | 47130 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Shreveport | Louisiana | 71106 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Missoula | Montana | 59802 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Lawrenceville | New Jersey | 08648 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Mount Laurel | New Jersey | 08054 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Voorhees Township | New Jersey | 08043 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Brooklyn | New York | 11215 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Garden City | New York | 11530 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Poughkeepsie | New York | 12601 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Concord | North Carolina | 28025 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Raleigh | North Carolina | 27607 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Cincinnati | Ohio | 45212 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669 | Columbus | Ohio | 43221 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Bethany | Oklahoma | 73008 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Salem | Oregon | 97301 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669 | Bala-Cynwyd | Pennsylvania | 19004 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Lancaster | Pennsylvania | 17604 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Myrtle Beach | South Carolina | 29572 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Knoxville | Tennessee | 37920 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Arlington | Texas | 76017 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Carrollton | Texas | 75010 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Dallas | Texas | 75231 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Salt Lake City | Utah | 84107 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00918983, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 30, 2014 · Synced Nov 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.